Early research (Phase 1)Study completedNCT00049296What this trial is testingThalidomide and Docetaxel in Treating Patients With Advanced CancerWho this might be right forCancer Case Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Looking for participantsNCT07135544What this trial is testingA Single-arm, Multicenter, Exploratory Study of Adebrelimab Combined With Apatinib and Systemic Chemotherapy for Initially Unresectable Biliary Tract CancerWho this might be right forBiliary Tract CancerBiliary Tract Cancer (CCA) Yongjun Chen 37
Not applicableStudy completedNCT05028439What this trial is testingRFA Combined With Chemotherapy for Unresectable CholangiocarcinomaWho this might be right forCholangiocarcinoma First People's Hospital of Hangzhou 70
Testing effectiveness (Phase 2)Active Not RecruitingNCT05564403What this trial is testingStudy of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A ComboMATCH Treatment Trial)Who this might be right forAdvanced Biliary Tract CarcinomaAdvanced Gallbladder CarcinomaAdvanced Intrahepatic Cholangiocarcinoma+14 more National Cancer Institute (NCI) 66
Large-scale testing (Phase 3)Study completedNCT00391183What this trial is testingPalliative Biliary Stenting on the Quality of Life of Patients With Unresectable Carcinoma Gallbladder With Hiliar Block.Who this might be right forGallbladder Cancer All India Institute of Medical Sciences 60
Large-scale testing (Phase 3)Study completedNCT04003636What this trial is testingPembrolizumab (MK-3475) Plus Gemcitabine/Cisplatin Versus Placebo Plus Gemcitabine/Cisplatin for First-Line Advanced and/or Unresectable Biliary Tract Carcinoma (BTC) (MK-3475-966/KEYNOTE-966)Who this might be right forBiliary Tract Carcinoma Merck Sharp & Dohme LLC 1,069
Not applicableStudy completedNCT00477919What this trial is testingE-MOSAIC Electronic Tool to Monitor SymptomsWho this might be right forCancer Swiss Cancer Institute 264
Testing effectiveness (Phase 2)UnknownNCT01811277What this trial is testingSOX Sequential S-1 in Advanced Biliary Tract Carcinoma（BTC）and Pancreatic CancerWho this might be right forBiliary Tract CancerPeriampullary AdenocarcinomaPancreatic Cancer Peking University 40
Early research (Phase 1)Study completedNCT00654160What this trial is testingIrinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal CancerWho this might be right forAnal CancerCarcinoma of the AppendixColorectal Cancer+9 more Mayo Clinic 7
Testing effectiveness (Phase 2)Ended earlyNCT04203160What this trial is testingGemcitabine and Cisplatin With or Without CPI-613 as First Line Therapy for Patients With Advanced Unresectable Biliary Tract Cancer (BilT-04)Who this might be right forBiliary Tract Cancer University of Michigan Rogel Cancer Center 75
Not applicableStudy completedNCT03729882What this trial is testingPrimary EUS-GBD in Patients With Unresectable Malignant Biliary Obstruction and Cystic Duct Orifice Involvement.Who this might be right forAcute Cholecystitis Instituto Ecuatoriano de Enfermedades Digestivas 22
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07623642What this trial is testingA Phase II Study of GV20-0251 in Combination With Anti-PD-1 Monoclonal Antibodies in Patients With Unresectable, Locally Advanced, or Metastatic Solid Tumors.Who this might be right forUterine Cervical NeoplasmsTriple Negative Breast NeoplasmsProstatic Neoplasms+8 more GV20 Therapeutics 227
Large-scale testing (Phase 3)Ended earlyNCT00387348What this trial is testingEscitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal CancerWho this might be right forColorectal CancerDepressionEsophageal Cancer+7 more Massachusetts General Hospital 24
Early research (Phase 1)Study completedNCT00003867What this trial is testingIrinotecan and Capecitabine in Treating Patients With Solid TumorsWho this might be right forCancer Montefiore Medical Center 30
Not applicableStudy completedNCT01294085What this trial is testingCase Series Study of Biliary Tract Cancer Patients in JapanWho this might be right forBiliary Tract Cancer Kansai Hepatobiliary Oncology Group 300
Testing effectiveness (Phase 2)Active Not RecruitingNCT07654530What this trial is testingSintilimab Combined With Ipilimumab (N01) Plus AG as First-line Therapy for uBTC.Who this might be right forBiliary Tract Cancers (BTC) Tianjin Medical University Cancer Institute and Hospital 107
Testing effectiveness (Phase 2)Looking for participantsNCT07506057What this trial is testingTrastuzumab in Combination With Serplulimab and Chemotherapy for the Treatment of HER2-overexpressing Unresectable Locally Advanced or Metastatic Biliary Tract Cancer or Urothelial Carcinoma After Failure of Standard TherapyWho this might be right forUrothelial CarcinomaBiliary Tract CancerHER2 Xiujuan Qu 20
Post-approval studies (Phase 4)Ended earlyNCT01887041What this trial is testingQuality of Life After Biliodigestive Anastomosis (BDA) or Stents to Treat Biliary Obstruction in Pancreas CancerWho this might be right forLocal Tumor SpreadAdvanced CancerMetastasized+2 more Universitätsklinikum Hamburg-Eppendorf 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT02632305What this trial is testingSee the Effects That a New Combination of the Three Drugs, Nab-paclitaxel, Gemcitabine, and Cisplatin Has on Biliary Tract CancerWho this might be right forUnresectable Biliary Tract Cancer AHS Cancer Control Alberta 45
Large-scale testing (Phase 3)Ended earlyNCT02082522What this trial is testingEfficacy and Safety Study of PDT Using Photofrin in Unresectable Advanced Perihilar Cholangiocarcinoma (OPUS)Who this might be right forHilar Cholangiocarcinoma Concordia Laboratories Inc. 28